All In MedTech

Device Trial Radar · NCT04015219

Management of Signs and Symptoms Associated With Dry Eye Disease

A Prospective, Randomized, and Controlled Clinical Study to Evaluate PROKERA® in the Management of Signs and Symptoms Associated With Dry Eye Disease

Last checked: Nov 19, 2026Latest source record: Dec 23, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

3

Actual

Start

Jul 18, 2018

Primary completion

Oct 5, 2020

Study completion Oct 5, 2020

Sponsor

Lead sponsor
BioTissue Holdings, IncNot on our public-company list
Sponsor type
Industry
First posted
Jul 10, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A prospective randomized, and controlled study to compare the effectiveness of PROKERA® SLIM plus standard of care (SOC) in the PROKERA® SLIM Arm to SOC alone in the Control Arm. Subjects presenting with moderate DED defined as corneal fluorescein staining score of ≥ 3 points out of 9 will be recruited.

Conditions

  • Dry Eye Syndromes

Interventions

  • Self retained cryopreserved amniotic membraneDevice

    PROKERA SLIM

  • lifitegrast ophthalmic solutionOther

    Xiidra® (5% lifitegrast ophthalmic solution, Shire, Lexington, MA)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Corneal Fluorescein StainingTime frame: 1 month

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Center of Excellence in Eye Care

    Miami, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.